Dosage forms of risedronate

Details for Australian Patent Application No. 2011218625 (hide)

Owner Warner Chilcott Company, LLC

Inventors Dansereau, Richard John; Burgio Jr., David Ernest

Agent Pizzeys

Pub. Number AU-A-2011218625

Parent 2005330654

Filing date 29 August 2011

Wipo publication date 15 September 2011

International Classifications

A61K 9/32 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/28 (2006.01) Medicinal preparations characterised by special physical form - Dragees

A61K 9/36 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/42 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/58 (2006.01) Medicinal preparations characterised by special physical form

A61K 31/675 (2006.01) - having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate

A61P 19/10 (2006.01) Drugs for skeletal disorders

Event Publications

15 September 2011 Application Open to Public Inspection

  Published as AU-A-2011218625

15 September 2011 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011218626-Delay units and methods of making the same

2011218624-Agents and methods for diagnosing stress